Taishotoyama symposium barriers to colorectal cancer screening: Economics, capacity and adherence

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue SUPPL. 2, 2008, Pages

  Inadomi, John M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Colonoscopy; Colorectal cancer; Fecal occult blood; Health services; Mass screening; Medical economics

Indexed keywords

CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; HEALTH CARE COST; HUMAN; INCIDENCE; LIFE EXPECTANCY; PATIENT COMPLIANCE; PRIORITY JOURNAL; SIGMOIDOSCOPY;

EID: 57449113420     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05556.x     Document Type: Conference Paper

References (41)

1. Wilson JMG, Jungner F. Principles and Practice of Screening for Disease. Geneva : WHO, 1968. Public Health Papers; vol. 34.
2. Selby JV, Friedman GD, Quesenberry CP Jr., Weiss NS. Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Ann. Intern. Med. 1993 118 : 1 6.
3. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N. Engl. J. Med. 1993 328 : 1365 71.
4. Mandel JS, Church TR, Bond JH et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N. Engl. J. Med. 2000 343 : 1603 7.
5. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996 348 : 1467 71.
6. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996 348 : 1472 7.
7. Selby JV, Friedman GD, Quesenberry CP Jr., Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N. Engl. J. Med. 1992 326 : 653 7.
8. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J. Natl. Cancer Inst. 1992 84 : 1572 5.
9. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N. Engl. J. Med. 1993 329 : 1977 81.
10. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch. Intern. Med. 1995 155 : 1741 8.
11. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann. Intern. Med. 1995 123 : 904 10.
12. Inadomi JM, Sonnenberg A. The impact of colorectal cancer screening on life expectancy. Gastrointest. Endosc. 2000 51 : 517 23.
13. Wagner J, Tunis S, Brown M, Ching A, Almeida R. Cost Effectiveness of Colorectal Cancer Screening in Average-Risk Adults. Philadelphia, PA : WB Saunders, 1996 321 41.
14. Wagner JL, Herdman RC, Wadhwa S. Cost effectiveness of colorectal cancer screening in the elderly. Ann. Intern. Med. 1991 115 : 807 17.
15. Eddy DM, Nugent FW, Eddy JF et al. Screening for colorectal cancer in a high-risk population. Results of a mathematical model. Gastroenterology 1987 92 : 682 92.
16. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000 284 : 1954 61.
17. Khandker RK, Dulski JD, Kilpatrick JB, Ellis RP, Mitchell JB, Baine WB. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int. J. Technol. Assess. Health Care 2000 16 : 799 810.
18. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann. Intern. Med. 2000 133 : 573 84.
19. Vijan S, Hwang EW, Hofer TP, Hayward RA. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am. J. Med. 2001 111 : 593 601.
20. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2002 137 : 96 104.
21. Bolen JC, Rhodes L, Powell-Griner EE, Bland SD, Holtzman D. State-specific prevalence of selected health behaviors, by race and ethnicity - Behavioral Risk Factor Surveillance System, 1997. MMWR Surveill. Summ. 2000 49 : 1 60.
22. Janes GR, Blackman DK, Bolen JC et al. Surveillance for use of preventive health-care services by older adults, 1995-1997. MMWR Surveill. Summ. 1999 48 : 51 88.
23. Perez-Stable EJ, Sabogal F, Otero-Sabogal R. Use of cancer-screening tests in the San Francisco Bay area: comparison of Latinos and Anglos. J. Natl. Cancer Inst. Monogr. 1995 18 : 147 53.
24. Hiatt RA, Perez-Stable EJ, Quesenberry C Jr., Sabogal F, Otero-Sabogal R, McPhee SJ. Agreement between self-reported early cancer detection practices and medical audits among Hispanic and non-Hispanic white health plan members in northern California. Prev. Med. 1995 24 : 278 85.
25. Perez-Stable EJ, Otero-Sabogal R, Sabogal F, McPhee SJ, Hiatt RA. Self-reported use of cancer screening tests among Latinos and Anglos in a prepaid health plan. Arch. Intern. Med. 1994 154 : 1073 81.
26. Myers RE, Ross EA, Wolf TA, Balshem A, Jepson C, Millner L. Behavioral interventions to increase adherence in colorectal cancer screening. Med. Care 1991 29 : 1039 50.
27. Myers RE, Balshem AM, Wolf TA, Ross EA, Millner L. Adherence to continuous screening for colorectal neoplasia. Med. Care 1993 31 : 508 19.
28. Myers RE, Trock BJ, Lerman C, Wolf T, Ross E, Engstrom PF. Adherence to colorectal cancer screening in an HMO population. Prev. Med. 1990 19 : 502 14.
29. Anderson R, Newman J. Societal and individual determinants of medical care utilization in the United States. Milbank Mem. Fund Q. 1972 50 : 95 124.
30. Myers RE, Ross E, Jepson C et al. Modeling adherence to colorectal cancer screening. Prev. Med. 1994 23 : 142 51.
31. Vernon SW. Participation in colorectal cancer screening: a review. J. Natl. Cancer Inst. 1997 89 : 1406 22.
32. Walsh JM, Posner SF, Perez-Stable EJ. Colon cancer screening in the ambulatory setting. Prev. Med. 2002 35 : 209 18.
33. Hynam KA, Hart AR, Gay SP, Inglis A, Wicks AC, Mayberry JF. Screening for colorectal cancer: reasons for refusal of faecal occult blood testing in a general practice in England. J. Epidemiol. Community Health 1995 49 : 84 6.
34. Harewood GC, Wiersema MJ, Melton LJ 3rd. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am. J. Gastroenterol. 2002 97 : 3186 94.
35. Kremers SP, Mesters I, Pladdet IE, van den Borne B, Stockbrugger RW. Participation in a sigmoidoscopic colorectal cancer screening program: a pilot study. Cancer Epidemiol. Biomarkers Prev. 2000 9 : 1127 30.
36. Link A, Cram P, Dwamena B, Inadomi JM. Virtual colonoscopy, real misses. Am. J. Gastroenterol. 2003 98 (9 Suppl. S235.
37. Vijan S, Inadomi J, Hayward RA, Hofer TP, Fendrick AM. Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment. Pharmacol. Ther. 2004 20 : 507 15.
38. Brown ML, Klabunde CN, Mysliwiec P. Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices. Am. J. Med. 2003 115 : 129 33.
39. Rawl S, Champion V, Menon U, Loehrer PJ, Vance GH, Sugg Skinner C. Validation of scales to measure benefits of and barriers to colorectal cancer screening. J. Psychosoc. Oncol. 2001 19 : 47 63.
40. Janz NK, Wren PA, Schottenfeld D, Guire KE. Colorectal cancer screening attitudes and behavior: a population-based study. Prev. Med. 2003 37 : 627 34.
41. Myers RE, Vernon SW, Tilley BC, Lu M, Watts BG. Intention to screen for colorectal cancer among white male employees. Prev. Med. 1998 27 : 279 87.